subcutaneous injection
Sponsors
Ferring Pharmaceuticals A/S, Yamaoka Kunihiro, Mannkind Corporation, Massachusetts General Hospital, McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions
Diabetes Mellitus, Type 2Eosinophilic Gastrointestinal Disorders (EGIDs)Idiopathic male infertility (including oligoasthenozoospermia).LeiomyomaRheumatoid Arthritis
Rheumatoid ArthritisType 1 Diabetes
Phase 1
Phase 2
Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 Diabetes
NCT01684956
Start: 2012-08-31End: 2017-12-31Target: 20Updated: 2016-09-07
Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization
CompletedNCT02270255
Start: 2015-04-30End: 2017-11-01Updated: 2019-08-14
A randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of FE 999049 for treatment of men with idiopathic infertility
CompletedCTIS2023-508430-34-00
Start: 2023-01-12End: 2024-10-23Target: 197Updated: 2024-10-16